Inhibition of CD44v9 upregulates the invasion ability of oral squamous cell carcinoma cells

Oral Oncology

Volumn 39, Issue 1, 2003, Pages 27-30

  Sato, S ^a   Miyauchi, M ^a   Ogawa, I ^b   Kudo, Y ^a   Kitagawa, S ^a   Hiraoka, M ^a   Takata, T ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

CO44v9; Invasion; Squamous cell carcinoma

Indexed keywords

CD44V ANTIGEN; CD44V9 ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL ADHESION; CELL STRAIN; CONTROLLED STUDY; HUMAN; HUMAN CELL; METASTASIS; MOUTH CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REDUCTION; SQUAMOUS CELL CARCINOMA; UPREGULATION;

ANTIGENS, CD44; ANTIGENS, NEOPLASM; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; HUMANS; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0037210618     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(01)00132-4     Document Type: Article

References (16)

1. Kaufmann M., Heider K.H., Sinn H., von Minckwitz G., Ponta H., Herrlich P. CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet. 345(8950):1995;615-619.
2. Dall P., Heider K.H., Sinn H.P., Skroch-Angel P., Adolf G., Kaufmann M., Herrlich P., Ponta H. Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer. Int J Cancer. 60(4):1995;471-477.
3. Tokue Y., Matsumura Y., Katsumata N., Watanabe T., Tarin D., Kakizoe T. CD44 variant isoform expression and breast cancer prognosis. Jpn J Cancer Res. 89(3):1998;283-290.
4. Matsumura Y., Tarin D. Sifnificance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet. 340(8827):1992;1053-1058.
5. Terpe H.J., Storkel S., Zimmer U., Anquez V., Fischer C., Pantel K., Gunthert U. Expression of CD44 isoform in renal cell tumors. Positive correlation to tumor differentiation. Am J Pathol. 148(2):1996;453-463.
6. Stauder R., Eisterer W., Thaler J., Gunthert U. CD44 variant isoforms in non-Hodgkin's lymphoma. a new independent prognostic factor Blood. 85(10):1995;2885-2899.
7. Ristamaki R., Joensuu H., Soderstorm K.O., Jalkanen S. CD44v6 expression in non-Hodgkin's lymphoma. an association with low histological grade and poor prognosis J Pathol. 176(3):1995;259-267.
8. Oliveira D.T., Sherriff M., Odell E.W. Expression of CD44 variant exons by primary and metastatic oral squamous carcinomas. J Oral Pathol Med. 27(7):1998;303-307.
9. Ue T., Yokozaki H., Kagai K., Higashikawa K., Yasui W., Sugiyama M., Tahara E., Ishikawa T. Reduced expression of the CD44 variant exons in oral squamous cell carcinoma and its relationship to metastasis. J Oral Pathol Med. 27(5):1998;197-201.
10. Kunishi M., Kayada Y., Yoshiga K. Down-regulated expression of CD44 variant 6 in oral squamous cell carcinomas and its relationship to regional lymph node metastasis. Int J Oral Maxillofac Surg. 26(4):1997;280-283.
11. Sato S., Miyauchi M., Takekoshi T., Zhao M., Kudo Y., Ogawa I., Kitagawa S., Fujita M., Takata T. Reduced expression of CD44 variant 9 is related to lymph node metastasis and poor survival in squamous cell carcinoma of tongue. Oral Oncol. 36(6):2000;545-549.
12. Woodhouse E.C., Chuaqui R.F., Liotta L.A. General mechanisms of metastasis. Cancer. 80(Suppl. 8):1997;1529-1537.
13. Kanke M., Fujii M., Kameyama K., Kanzaki J., Tokumaru Y., Imanishi Y., Tomita T., Matsumura Y. Role of CD44 variant exon 6 in invasion of head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 126(10):2000;1217-1223.
14. Takahashi K., Eto H., Tanabe K.K. Involvement of CD44 in matrix metalloproteinase-2 regulation in human melanoma cells. Int J Cancer. 80(3):1999;387-395.
15. Tsukita S., Oishi K., Sato N., Sagara J., Kawai A., Tsukita S. ERM family members as molecular linkers between the cell surface clycoprotein CD44 and actin-based cytoskeletons. J Cell Biol. 126(2):1994;391-401.
16. Hirao M., Sato N., Kondo T., Yonemura S., Monden M., Sasaki T., Takai Y., Tsukita S., Tsukita S. Regulation mechanism of ERM (ezrin/radixin/moesin) protein/plasma membrane association. possible involvement of phosphatidylinositol turnover and Rho-dependent signaling pathway J Cell Biol. 135(1):1996;37-51.